GEN1079 / Genmab - LARVOL DELTA

Trial to Evaluate the Safety and Preliminary Efficacy of GEN1079 in Participants With Advanced Solid Tumors (clinicaltrials.gov) - P1 | N=121 | Recruiting | Sponsor: Genmab | Not yet recruiting ➔ Recruiting

Enrollment open • First-in-human • Oncology • Solid Tumor